The global Infant Phototherapy Device market size is USD 105.9 million in 2024.

According to Cognitive Market Research, the global Infant Phototherapy Device market size will be USD 105.9 million in 2024. It will expand at a compound annual growth rate (CAGR) of 4.00% from 2024 to 2031.North America held the major market share for more than 40% of the global revenue with a market size of USD 42.36 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.2% from 2024 to 2031.Europe accounted for a market share of over 30% of the global revenue with a USD 31.77 million market size.Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 24.36 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.0% from 2024 to 2031.Latin America had a market share of more than 5% of the global revenue with a market size of USD 5.30 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.4% from 2024 to 2031.Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 2.12 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031.The Fixed device held the highest Infant Phototherapy Device market revenue share in 2024.  Market Dynamics of Infant Phototherapy Device MarketKey Drivers for Infant Phototherapy Device MarketRising Incidence of Neonatal Jaundice Globally to Increase the Demand GloballyThe Infant Phototherapy Device market is experiencing growth owing to the rising incidence of neonatal jaundice globally. Neonatal jaundice, characterized by high bilirubin levels in newborns, requires effective treatment to prevent severe health complications. Phototherapy is a widely accepted and effective method to manage this condition, increasing the demand for infant phototherapy devices. According to the National Library of Medicine, Neonatal jaundice affects up to 80% of preterm and term newborns, with severe cases requiring treatment to prevent complications like bilirubin encephalopathy and kernicterus. As the incidence of neonatal jaundice rises especially in emerging markets, the need for these devices continues to grow. This increasing focus on improving neonatal care worldwide propels the market forward.Increased Awareness of Infant Healthcare to Propel Market GrowthThe infant phototherapy device market has witnessed steady growth, driven by increasing awareness of infant healthcare. Parents and healthcare providers are becoming more educated about the importance of early diagnosis and treatment of neonatal conditions like jaundice. This growing awareness leads to a higher demand for effective treatments, such as phototherapy devices. Furthermore, health awareness campaigns that have been organized by governments and various agencies have also contributed to this increasing perception concerning child health. Hence hospitals as well as neonatal clinics are compelled to acquire improved equipment for phototherapy purposes increasing the market growth.Restraint Factor for the Infant Phototherapy Device MarketHigh Cost of Advanced Phototherapy Devices Limit The Sales of the MarketThe Infant Phototherapy Device market is restrained by the high cost of advanced phototherapy devices. The cost of these devices, which are essential for treating newborns, can be expensive, limiting their availability, especially in low-income settings and smaller healthcare facilities. Costs limit the ability of hospitals and clinics, especially in developing countries, to invest in this vital equipment. As a result, some healthcare providers rely on older, ineffective equipment or new treatments, which can affect the quality of newborn care. Economic constraints due to the high cost of advanced equipment slow market growth, hindering the widespread use of the latest technologies in newborn healthcare.Impact of Covid-19 on the Infant Phototherapy Device MarketThe Infant Phototherapy Device Market has been experiencing growth driven by the increasing prevalence of neonatal jaundice and advancements in phototherapy technology. Key drivers include rising awareness of infant healthcare, expanding neonatal care units, and the development of portable devices. However, the COVID-19 pandemic led to temporary setbacks in the market. Lockdowns and disruptions in the supply chain caused delays in the manufacturing and distribution of infant phototherapy devices. Healthcare budgets we...

据认知市场研究显示，全球婴儿光疗设备市场规模预计在2024年将达到1.059亿美元，并从2024年至2031年以4.00%的复合年增长率（CAGR）持续扩张。北美市场占据了全球收入的超过40%份额，2024年的市场规模为4.236亿美元，并将在2024年至2031年以2.2%的CAGR增长。欧洲市场在全球收入中占比超过30%，市场规模为3.177亿美元。亚太地区在全球收入中占比约为23%，2024年的市场规模为2.436亿美元，并将在2024年至2031年以6.0%的CAGR增长。拉丁美洲在全球收入中占比超过5%，2024年的市场规模为530万美元，并将在2024年至2031年以3.4%的CAGR增长。中东和非洲在全球收入中占比约为2%，2024年的市场规模估计为212万美元，并将在2024年至2031年以3.7%的CAGR增长。固定设备在2024年占据了婴儿光疗设备市场最高的收入份额。
婴儿光疗设备市场的市场动态包括市场驱动因素、市场阻力因素以及COVID-19对市场的影响。
市场驱动因素包括全球新生儿黄疸发病率上升，这增加了全球对光疗设备的需求。新生儿黄疸以新生儿胆红素水平升高为特征，需要有效的治疗以预防严重的健康并发症。光疗是一种广泛接受且有效的治疗方法，增加了对婴儿光疗设备的需求。根据美国国家医学图书馆的数据，新生儿黄疸可影响多达80%的早产儿和足月新生儿，严重病例需要治疗以预防胆红素脑病和核黄疸等并发症。随着新生儿黄疸发病率在新兴市场中的上升，对这些设备的需求持续增长。全球范围内对新生儿护理改善的日益关注推动了市场的发展。
市场阻力因素包括高级光疗设备的高成本限制了市场的销售。这些设备对于治疗新生儿至关重要，但成本可能很高，限制了其可用性，尤其是在低收入环境和较小的医疗设施中。成本限制了医院和诊所，尤其是在发展中国家，投资这些关键设备的能力。因此，一些医疗服务提供者依赖于较旧、效果不佳的设备或新疗法，这可能影响新生儿护理的质量。由于高级设备的高成本造成的经济限制减缓了市场增长，阻碍了新生儿医疗保健领域最新技术的广泛应用。
COVID-19疫情对婴儿光疗设备市场的影响表现为，尽管新生儿黄疸的普遍性和光疗技术的进步推动了市场的增长，但COVID-19大流行导致市场暂时出现挫折。封锁和供应链中断导致婴儿光疗设备的制造和分销延迟。医疗预算由于高级设备的高成本而受到限制，阻碍了新生儿医疗保健领域最新技术的广泛应用。